Lucid Adds Potential for Neurodegenerative Disease Treatments and Mental Health in a Novel Way TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, is pleased to announce the completion …Read More »
Cannabis Stock Market
FSD PHARMA ANNOUNCES ENGAGEMENT WITH CAPITAL MARKETS COMMUNICATIONS PROVIDERS AND MARKET MAKER
TORONTO–(BUSINESS WIRE)– FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today it has retained the services of Hybrid Financial Ltd. (“Hybrid”), North Equities Corp. (the “North Equities“), Looking …Read More »
Could This Little-Known Pot Stock Double Your Money?
Key Points High Tide will have more than 100 cannabis stores across Canada by the end of this year.The company just expanded into the U.S. by acquiring online retailer Fab Nutrition.Over the next 12 months, its sales are on track to top more than 200 million Canadian dollars. There are …Read More »
FSD PHARMA ANNOUNCES CLOSING OF LUCID PSYCHECEUTICALS ACQUISITION
Lucid Adds Potential for Neurodegenerative Disease Treatments and Mental Health in a Novel Way TORONTO–(BUSINESS WIRE)– FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, is pleased to announce the …Read More »
Valens to Acquire Craft Cannabis Producer Citizen Stash in $54 Million Stock-Based Deal
The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company,” “The Valens Company” or “Valens”) and Citizen Stash Cannabis Corp. (“Citizen Stash”) (formerly Experion Holdings Ltd) (TSXV: CSC) (OTCQB: EXPFF) (FRANKFURT: MB31) are pleased to announce they have entered into an arrangement agreement (the “Agreement”) pursuant to which Valens will acquire …Read More »
Hexo eyes California cannabis market for upcoming investment
Hexo Corp. plans to enter the U.S. cannabis market through an investment in a California-based company that leverages the Canadian company’s manufacturing prowess, the company’s chief executive said Friday. The company created a special purpose vehicle to invest in the U.S. market while remaining onside with regulatory requirements from the …Read More »
Aurora (TSX:ACB) Stock Is Down $15 From Its Peak in February: Buy Now?
Optimism among Canadian cannabis producers was high when Democrat Joe Biden won the U.S. presidency in November 2020. Three senators from the party promised legislation in early February 2021 that would end the federal prohibition on marijuana. Weed stocks rallied, including Aurora Cannabis (TSX:ACB)(NYSE:ACB). From $10.60 on December 31, 2020, the share …Read More »
Do You Trade Canadian Marijuana Stocks? 2 You Should Know About In 2021
Top Canadian Marijuana Stocks To Watch This Month During the 2nd half of July, marijuana stocks have been showing a bit more action in the market. Now with this upward momentum has also come a bit of volatile trading. With the sector beginning to fluctuate in price more often, those looking to …Read More »
2 Undervalued Marijuana Stocks To Watch In July
2 Marijuana Stocks To Watch This Friday With Hidden Value. When looking for marijuana stocks to buy often times people look for the top companies only. This is typically done due to the value and popularity of the given cannabis stock. Most times investors try to invest in what is currently popping …Read More »
The Cannara Effect: Canadian investors have a major opportunity with this Quebec-based cannabis company
Canada’s cannabis market is continuing its upward trajectory with a current market size of $2.7 billion Cannara Biotech has entered into a definitive agreement to acquire a one million square foot state-of-the-art cultivation and manufacturing facility from The Green Organic Dutchman Holdings through an all-cash offer of $27 million. The estimated cost of construction …Read More »
Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.
Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.
Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.
Investment Value Finders is intended for those 21+ years of age only!